Peter Jessica, Abdulkadir Ahmed, Kaller Christoph, Kümmerer Dorothee, Hüll Michael, Vach Werner, Klöppel Stefan
Department of Neurology, University Medical Centre Freiburg, Germany Freiburg Brain Imaging, University Medical Centre Freiburg, Germany Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, Germany.
Freiburg Brain Imaging, University Medical Centre Freiburg, Germany Group of Pattern Recognition and Image Processing, Department of Computer Science, University of Freiburg, Germany.
J Alzheimers Dis. 2014;42(2):651-61. doi: 10.3233/JAD-140261.
Although episodic memory impairment is usually the earliest sign of Alzheimer's disease (AD), there are up to 15% of patients presenting with early impairment in non-memory cognitive functions (i.e., atypical AD). Stratifying patients with AD may aid clinical trials. Previous studies divided patients by cognitive profile, focusing on cross-sectional analyses without testing stability of clusters over time. We used principal component analysis followed by cluster analyses in 127 patients with AD based on 24 cognitive scores at 0, 6, 12, and 24 months follow-up. We investigated the definition of clusters and their stability over time as well as interactions of cluster assignment and disease severity. At each time point, six distinct factors and four distinct clusters were extracted that did not differ substantially between time points. Clusters were defined by cognitive profile rather than disease severity. 85% of patients fell into the same cluster twice, 42% three times, and 17% four times. Subjects with focal semantic impairment progressed significantly faster than the other cluster. Longitudinally, focal deficits increased relatively rather than tending toward average disease severity. The observed similar cluster definitions at each time point indicate the validity of the approach. Cluster-specific longitudinal increases of focal impairments and significant between-cluster differences in disease progression make this approach useful for stratified inclusion into clinical trials.
尽管情景记忆障碍通常是阿尔茨海默病(AD)最早出现的症状,但高达15%的患者在非记忆认知功能方面存在早期损害(即非典型AD)。对AD患者进行分层可能有助于临床试验。以往的研究根据认知特征对患者进行划分,侧重于横断面分析,而未测试不同组随时间的稳定性。我们对127例AD患者在随访0、6、12和24个月时的24项认知评分进行主成分分析,随后进行聚类分析。我们研究了不同组的定义及其随时间的稳定性,以及组分配与疾病严重程度之间的相互作用。在每个时间点,提取出六个不同的因素和四个不同的组,这些组在不同时间点之间没有显著差异。不同组是根据认知特征而非疾病严重程度来定义的。85%的患者两次归入同一组,42%的患者三次归入同一组,17%的患者四次归入同一组。有局灶性语义损害的受试者进展明显快于其他组。从纵向来看,局灶性缺陷相对增加,而不是趋向于平均疾病严重程度。在每个时间点观察到的相似的组定义表明了该方法的有效性。局灶性损害的组特异性纵向增加以及不同组在疾病进展方面的显著差异使得该方法对于分层纳入临床试验很有用。